Goldstuck Norman D, Steyn Petrus S
Department of Obstetrics and Gynaecology, Tygerberg Hospital, Cape Town, Western Cape, South Africa.
Reproductive Health and Fertility Regulation, Department of Obstetrics and Gynaecology, Groote Schuur Hospital and University of Cape Town, Cape Town, South Africa.
Int J Womens Health. 2013 Dec 4;5:811-8. doi: 10.2147/IJWH.S53845.
All postpartum women, including those who are breastfeeding or have had a cesarean section, appear potentially suited to intrauterine contraception, a long acting reversible contraceptive (LARC). Like any other method used after delivery, it should not interfere with lactation or be affected by cesarean section.
We searched the MEDLINE, PubMed, Popline, Google Scholar, and Clinicaltrials.gov databases from January 1968 through to December 2012. Studies were included if they reported event rates in women who had a cesarean section and event rates and clinical outcomes in lactating women or their infants in the breastfeeding group. Summary odds ratios were not calculated because of the diverse methods of reporting event rates in the cesarean section group and the heterogeneity of the results in the breastfeeding group.
We found 26 articles on event rates in interval and post-placental intrauterine device (IUD) use, and 18 on event rates and clinical outcomes in breastfeeding IUD users. Four prospective studies and one retrospective study showed an increased expulsion rate in interval insertion. There were 19 studies, of which five were controlled in post-placental IUD insertion after cesarean section. Four studies had expulsion rates of 10 or more per 100 woman-years of use and 15 expulsion rates below 10 per 100 woman-years of use. Three studies showed that event rates for lactating IUD users are the same as those for non-lactating users. Fifteen controlled studies showed that the IUD had no effect on milk production and seven of these showed no effect on infant growth. Pharmacovigilance databases report an increased rate of IUD perforations in lactating women, while the event rate studies report that insertion is generally easier and less painful than expected. These were uncontrolled reports.
The IUD is a long-acting reversible method of contraception with expulsion rates of 5-15 per 100 woman-years of use when used as a post-placental method immediately after cesarean section. As an interval procedure (6 or more weeks after cesarean section) it appears to have a high expulsion rate (5% or higher) notably in older devices. The IUD does not affect breastfeeding and is easy to insert in these women, but appears to be associated with a higher perforation rate (>1 per 100). Providers should not be deterred from using this contraception method, especially in developing countries, but should be attentive to preventing these potential problems.
所有产后女性,包括正在哺乳或接受过剖宫产的女性,似乎都适合使用宫内节育器,这是一种长效可逆避孕方法(LARC)。与分娩后使用的任何其他方法一样,它不应干扰哺乳,也不受剖宫产的影响。
我们检索了1968年1月至2012年12月的MEDLINE、PubMed、Popline、谷歌学术和Clinicaltrials.gov数据库。如果研究报告了剖宫产女性的事件发生率以及母乳喂养组中哺乳期女性或其婴儿的事件发生率和临床结局,则纳入该研究。由于剖宫产组报告事件发生率的方法多样,且母乳喂养组结果存在异质性,因此未计算汇总比值比。
我们找到了26篇关于间隔期和胎盘娩出后宫内节育器(IUD)使用事件发生率的文章,以及18篇关于母乳喂养IUD使用者事件发生率和临床结局的文章。四项前瞻性研究和一项回顾性研究显示间隔期放置时排出率增加。有19项研究,其中五项对剖宫产术后胎盘娩出后放置IUD进行了对照。四项研究的排出率为每100妇女年10次或更多,15项研究的排出率低于每100妇女年10次。三项研究表明,哺乳期IUD使用者的事件发生率与非哺乳期使用者相同。15项对照研究表明,IUD对产奶量没有影响,其中7项研究表明对婴儿生长没有影响。药物警戒数据库报告哺乳期妇女IUD穿孔率增加,而事件发生率研究报告放置通常比预期更容易且疼痛更小。这些都是无对照报告。
宫内节育器是一种长效可逆避孕方法,在剖宫产术后立即作为胎盘娩出后方法使用时,每100妇女年的排出率为5 - 15次。作为间隔期程序(剖宫产术后6周或更长时间),它似乎有较高的排出率(5%或更高),特别是在较旧的装置中。IUD不影响母乳喂养,且在这些女性中易于放置,但似乎与较高的穿孔率(>每100例中有1例)相关。医疗服务提供者不应因此而不敢使用这种避孕方法,尤其是在发展中国家,但应注意预防这些潜在问题。